The Clinton Herald

TO YOUR GOOD HEALTH: Surgery is prudent if conservative treatment of neuroma fails

I am a 68-year-old woman who is in relatively good health. My primary exercise is walking my dogs anywhere from 2-5 miles per ...
TipRanks on MSN

AtriCure’s HEAL-IST IDE Trial: A Promising Step in Treating Inappropriate Sinus Tachycardia

Atricure, Inc. (($ATRC)) announced an update on their ongoing clinical study. Study Overview: The HEAL-IST IDE Trial, officially titled ‘Hybrid ...
The Malaysian Reserve

TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn’s disease at two years

Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...